Form 4 for INDP Indaptus Therapeutics, Inc.
Accepted 2024-08-08 00:00:00 ET · period of report 2024-08-08 · accession 0001493152-24-030839 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-08 | 2024-08-08 | INDP | Meckler Jeffrey A | CEO, Dir | A - Grant | $1.83 | +84.9K | 160.3K | +113% | +$155.4K |
| D | 2024-08-08 | 2024-08-08 | INDP | Meckler Jeffrey A | CEO, Dir | A - Grant | $1.83 | +84.9K | 84.9K | New | +$155.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-08-08 | A | A | 84,932 | $1.83 | 160,306 | D | — | — | (F1) The Reporting Person acquired 84,932 shares of common stock and 84,932 warrants to purchase common stock from the Issuer for an aggregate purchase price of $155,000.90. |
| 2 | Derivative | Common Stock Warrants | 2024-08-08 | A | A | 84,932 | $1.83 | 84,932 | D | $1.70 · — to 2029-08-08 | 84,932 Common Stock | (F1) The Reporting Person acquired 84,932 shares of common stock and 84,932 warrants to purchase common stock from the Issuer for an aggregate purchase price of $155,000.90. |